يعرض 1 - 10 نتائج من 15 نتيجة بحث عن '"Cell Cycle Checkpoints drug effects"', وقت الاستعلام: 1.58s تنقيح النتائج
  1. 1
  2. 2

    المصدر: International Journal of Molecular Sciences, Vol 22, Iss 10989, p 10989 (2021)
    International Journal of Molecular Sciences

    وصف الملف: application/pdf

  3. 3

    المساهمون: Instituto de Investigação e Inovação em Saúde

    المصدر: Scientific Reports
    Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)

    وصف الملف: application/pdf

  4. 4

    المساهمون: Centre hospitalier Saint-Joseph Saint-Luc, Cardiovasculaire, métabolisme, diabétologie et nutrition (CarMeN), Hospices Civils de Lyon (HCL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Université de Lyon-Institut National des Sciences Appliquées (INSA)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Institut National de la Recherche Agronomique (INRA), Centre Hospitalier Lyon Sud [CHU - HCL] (CHLS), Hospices Civils de Lyon (HCL), Institut National de la Recherche Agronomique (INRA)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Hospices Civils de Lyon (HCL), Institut de biologie et chimie des protéines [Lyon] (IBCP), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS)

    المصدر: Acta diabetologica
    Acta diabetologica, 2019, 56 (12), pp.1239--1245. ⟨10.1007/s00592-019-01402-w⟩

    مصطلحات موضوعية: Endocrinology, Diabetes and Metabolism, Fulminant, medicine.medical_treatment, [SDV]Life Sciences [q-bio], Type 2 diabetes, 030204 cardiovascular system & hematology, Bioinformatics, Anti-PD-L1, B7-H1 Antigen, Autoimmune diabetes, Alpha cell pancreatic function, 0302 clinical medicine, Endocrinology, Fulminant diabetes, CTLA-4 Antigen, Lipoatrophy, Autoimmune lipodystrophy, Autoimmune pancreatitis, Diabetes Mellitus, Lipoatrophic, Autoimmune generalised lipoatrophy, Type 1/chemically induced/complications/diagnosis/epidemiology, General Medicine, Anti-PD-1, 3. Good health, Programmed death ligand 1 (PD-L1), Immunotherapy, Autoimmune Diseases/chemically induced/epidemiology/etiology, 030209 endocrinology & metabolism, Context (language use), Type 2/*chemically induced/diagnosis/epidemiology/immunology, Autoimmune Diseases, 03 medical and health sciences, Diabetes mellitus, Internal Medicine, medicine, Diabetes Mellitus, Protein Kinase Inhibitors/*adverse effects/therapeutic use, Humans, Decompensation, Immunotherapy/*adverse effects, Protein Kinase Inhibitors, CTLA-4 Antigen/antagonists & inhibitors/immunology, Immune checkpoint inhibitors side effects, business.industry, Programmed cell death-1 (PD-1), Pancreas volume, Cell Cycle Checkpoints, medicine.disease, Cell Cycle Checkpoints/drug effects/immunology, Lipoatrophic/chemically induced/epidemiology/immunology, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Exocrine pancreatic function, Beta cell pancreatic function, business, B7-H1 Antigen/antagonists & inhibitors/immunology

  5. 5

    المصدر: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
    Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
    instacron:RCAAP
    Foy, V, Schenk, M, Baker, K, Gomes, F, Lallo, A, Frese, K, Forster, M, Dive, C & Blackhall, F 2017, ' Targeting DNA damage in SCLC ', Lung Cancer, vol. 114, 11, pp. 12-22 . https://doi.org/10.1016/j.lungcan.2017.10.006

    مصطلحات موضوعية: 0301 basic medicine, Genome instability, Cancer Research, Cell cycle checkpoint, Lung Neoplasms, DNA Repair, Protein Kinase Inhibitors/therapeutic use, Piperazines, Cell Proliferation/drug effects, Small Cell Lung Carcinoma/genetics, 0302 clinical medicine, Phthalazines/therapeutic use, Aurora Kinases, Molecular Targeted Therapy, Etoposide, Genetics, Rad51 Recombinase/antagonists & inhibitors, Manchester Cancer Research Centre, Cytotoxins, Azepines, Oncology, Cell Cycle Checkpoints/genetics, Heterocyclic Compounds, 4 or More Rings/therapeutic use, Rad51 Recombinase/therapeutic use, 030220 oncology & carcinogenesis, medicine.drug, Pulmonary and Respiratory Medicine, Benzimidazoles/therapeutic use, Lung Neoplasms/genetics, DNA damage, DNA repair, Context (language use), Poly(ADP-ribose) Polymerase Inhibitors, Heterocyclic Compounds, 4 or More Rings, Genomic Instability, 03 medical and health sciences, Cell Proliferation/genetics, medicine, Cytotoxins/therapeutic use, Humans, CHLC ONC, Lung cancer, Lung Neoplasms/drug therapy, Protein Kinase Inhibitors, Cell Proliferation, business.industry, ResearchInstitutes_Networks_Beacons/mcrc, Pyrimidines/therapeutic use, Small Cell Lung Carcinoma/drug therapy, Cell Cycle Checkpoints, Carbolines/therapeutic use, Cell Cycle Checkpoints/drug effects, Etoposide/therapeutic use, medicine.disease, Small Cell Lung Carcinoma, Piperazines/therapeutic use, respiratory tract diseases, 030104 developmental biology, Pyrimidines, DNA Damage/drug effects, Genomic Instability/drug effects, Cancer cell, Cancer research, Phthalazines, Benzimidazoles, Azepines/therapeutic use, Rad51 Recombinase, DNA Damage/genetics, Poly(ADP-ribose) Polymerase Inhibitors/therapeutic use, business, Aurora Kinases/therapeutic use, Genomic Instability/genetics, Molecular Targeted Therapy/methods, Carbolines, DNA Damage

  6. 6

    المصدر: Cancer Medicine, Vol. 6, No 7 (2017) pp. 1652-1664
    Cancer Medicine

  7. 7
  8. 8
  9. 9

    المساهمون: Laboratoire d'Epidémiologie Moléculaire et de Pathologie Expérimentale Appliquée aux Maladies Infectieuses (LR11IPT04), Université de Tunis El Manar (UTM)-Institut Pasteur de Tunis, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP), Université de Tunis El Manar (UTM), Temple University [Philadelphia], Pennsylvania Commonwealth System of Higher Education (PCSHE), Laboratoire des Venins et Biomolécules Thérapeutiques - Laboratory of Venoms and Therapeutic Biomolecules (LR11IPT08), Institut Pasteur de Tunis, Centre Scientifique de Monaco (CSM), Laboratoire de Transmission, Contrôle et Immunobiologie des Infections - Laboratory of Transmission, Control and Immunobiology of Infection (LR11IPT02), Institut de Recherche sur le Cancer et le Vieillissement (IRCAN), Université Nice Sophia Antipolis (... - 2019) (UNS), COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Côte d'Azur (UCA), This work was supported by the Tunisian Ministry of Higher Education and Scientific Research, the Institut Pasteur International Network (RIIP) and the University of Nice Sophia Antipolis, the French National Institute of Cancer (INCA) and the French Association for cancer research (ARC).

    المصدر: Molecular Carcinogenesis
    Molecular Carcinogenesis, Wiley, 2016, 56, pp.18-35. ⟨10.1002/mc.22470⟩

    مصطلحات موضوعية: Models, Molecular, Vascular Endothelial Growth Factor A, MESH: Vascular Endothelial Growth Factor A/genetics, MESH: Neovascularization, Pathologic/drug therapy, MESH: Colonic Neoplasms/drug therapy, MESH: Colonic Neoplasms/pathology, Apoptosis, MESH: MAP Kinase Signaling System/drug effects, MESH: Cell Proliferation/drug effects, Lebein, MESH: Colon/drug effects, MESH: Animals, MESH: Colon/metabolism, Neovascularization, Pathologic, MESH: Antineoplastic Agents/pharmacology, Integrin beta1, MESH: Chickens, MESH: Neovascularization, Pathologic/genetics, disintegrin, tumor growth, colon cancer, Colonic Neoplasms, MESH: Antineoplastic Agents/therapeutic use, MESH: Models, Molecular, MESH: Apoptosis/drug effects, MESH: Cell Line, Tumor, Colon, MAP Kinase Signaling System, MESH: Vascular Endothelial Growth Factor A/metabolism, Down-Regulation, Mice, Nude, Antineoplastic Agents, MESH: Viper Venoms/therapeutic use, [SDV.CAN]Life Sciences [q-bio]/Cancer, Viper Venoms, MESH: Cell Cycle Checkpoints/drug effects, MESH: Viper Venoms/pharmacology, Cell Line, Tumor, MESH: Down-Regulation/drug effects, MESH: Mice, Nude, Animals, Humans, MESH: Integrin beta1/metabolism, [SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology, Cell Proliferation, cellular effectors, MESH: Humans, Cell Cycle Checkpoints, MESH: Colonic Neoplasms/metabolism, MESH: Reactive Oxygen Species/metabolism, MESH: Colonic Neoplasms/genetics, MESH: Neovascularization, Pathologic/metabolism, MESH: Neovascularization, Pathologic/pathology, MESH: Colon/pathology, Reactive Oxygen Species, Chickens, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology

  10. 10

    المصدر: Human Pathology, Vol. 42, No 11 (2011) pp. 1727-39